Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer’s disease patients-Reference-Cited by-同舟云学术

Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer’s disease patients

Published:2017-06-06 Issue:1 Volume:9 Page:
ISSN:1758-9193
Container-title:Alzheimer's Research & Therapy
language:en
Short-container-title:Alz Res Therapy

Author:

Bridel Claire,Hoffmann Torsten,Meyer Antje,Durieux Sisi,Koel-Simmelink Marleen A.,Orth Matthias,Scheltens Philip,Lues Inge,Teunissen Charlotte E.

Funder

Schweizerische Multiple Sklerose Gesellschaft

Publisher

Springer Science and Business Media LLC

Subject

Cognitive Neuroscience,Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1186/s13195-017-0266-6.pdf

Reference56 articles.

1. Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med. 2016;8:1–14.

2. Kummer MP, Heneka MT. Truncated and modified amyloid-beta species. Alzheimers Res Ther. 2014;6:28.

3. Andrew RJ, Kellett KA, Thinakaran G, Hooper NM. A Greek Tragedy: the growing complexity of Alzheimer Amyloid precursor protein proteolysis. J Biol Chem. 2016;291(37):19235–44.

4. Cescato R, Dumermuth E, Spiess M, Paganetti PA. Increased generation of alternatively cleaved beta-amyloid peptides in cells expressing mutants of the amyloid precursor protein defective in endocytosis. J Neurochem. 2000;74:1131–9.

5. Takeda K, Araki W, Akiyama H, Tabira T. Amino-truncated amyloid β-peptide (A β 5-40/42) produced from caspase-cleaved amyloid precursor protein is deposited in Alzheimer’s disease. FASEB J. 2004;18(14):1755–7.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pyroglutamylation modulates electronic properties and the conformational ensemble of the amyloid β‐peptide;Proteins: Structure, Function, and Bioinformatics;2024-03-04

2. Therapeutic potential of glutaminyl cyclases: Current status and emerging trends;Drug Discovery Today;2023-10

3. Functions of glutaminyl cyclase and its isoform in diseases;Visualized Cancer Medicine;2023

4. Computational Methods for the Design and Development of Glutaminyl Cyclase Inhibitors in Alzheimer’s Disease;Neuromethods;2023

5. Alterations in Self-Aggregating Neuropeptides in Cerebrospinal Fluid of Patients with Parkinsonian Disorders;Journal of Parkinson's Disease;2022-05-24